That is simply in vitro potency data.
The FDA initially requested further data in the form of another RCT - requesting high quality in vivo clinical data.
After the last CRL, MSB specifically said the fda requested further data, and they would supply that data in the form of another adult trial - clinical data.
Now, MSB has gone back to the bench top and gathered some sort of in vitro data (low quality evidence), which we have no information about, and everyone seems to think this is going to be the silver bullet.
It just doesn't make any sense to me - it's blindingly obvious they're planning on doing the adult trial prior to approval - your quote you posted even says they're planning on validating the potency data with the adult trial.
The FDA will require the adult trial before approval - in my opinion, all the signs, all the releases by MSB, everything the FDA has requested in the past point to this fact.
As always.... happy to be wrong. But I would be very surprised![]()
- Forums
- ASX - By Stock
- Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
That is simply in vitro potency data.The FDA initially requested...
-
-
- There are more pages in this discussion • 206 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
97.0¢ |
Change
0.030(3.19%) |
Mkt cap ! $1.110B |
Open | High | Low | Value | Volume |
94.0¢ | 98.0¢ | 92.0¢ | $3.342M | 3.477M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 33313 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 73982 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 33313 | 0.970 |
3 | 99109 | 0.965 |
5 | 168086 | 0.960 |
2 | 40000 | 0.955 |
6 | 72924 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 73982 | 2 |
0.980 | 50627 | 6 |
0.985 | 34746 | 2 |
0.990 | 69957 | 4 |
0.995 | 59746 | 2 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online